483 related articles for article (PubMed ID: 29227538)
21. Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages.
Yan W; Liu X; Ma H; Zhang H; Song X; Gao L; Liang X; Ma C
Gut; 2015 Oct; 64(10):1593-604. PubMed ID: 25608525
[TBL] [Abstract][Full Text] [Related]
22. Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells.
Ye Y; Song Y; Zhuang J; Wang G; Ni J; Xia W
J Cell Physiol; 2019 Feb; 234(2):1880-1888. PubMed ID: 30067868
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.
Zhang N; Chu ES; Zhang J; Li X; Liang Q; Chen J; Chen M; Teoh N; Farrell G; Sung JJ; Yu J
Oncotarget; 2014 Sep; 5(18):8330-40. PubMed ID: 25327562
[TBL] [Abstract][Full Text] [Related]
24. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
25. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
26. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
[TBL] [Abstract][Full Text] [Related]
27. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
28. Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model.
Rajasekaran D; Siddiq A; Willoughby JL; Biagi JM; Christadore LM; Yunes SA; Gredler R; Jariwala N; Robertson CL; Akiel MA; Shen XN; Subler MA; Windle JJ; Schaus SE; Fisher PB; Hansen U; Sarkar D
Oncotarget; 2015 Sep; 6(28):26266-77. PubMed ID: 26313006
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
30. STAT3 and AKT signaling pathways mediate oncogenic role of NRSF in hepatocellular carcinoma.
Ma M; Zhou Y; Sun R; Shi J; Tan Y; Yang H; Zhang M; Shen R; Xu L; Wang Z; Fei J
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1063-1070. PubMed ID: 32556117
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
[TBL] [Abstract][Full Text] [Related]
32. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
[TBL] [Abstract][Full Text] [Related]
33. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model.
Khan MS; Halagowder D; Devaraj SN
Chem Biol Interact; 2011 Aug; 193(1):12-21. PubMed ID: 21554863
[TBL] [Abstract][Full Text] [Related]
34. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization.
Li X; Wang Z; Zou Y; Lu E; Duan J; Yang H; Wu Q; Zhao X; Wang Y; You L; He L; Xi T; Yang Y
Immunol Res; 2015 Jun; 62(2):137-45. PubMed ID: 25846584
[TBL] [Abstract][Full Text] [Related]
36. Sympathetic nervous system promotes hepatocarcinogenesis by modulating inflammation through activation of alpha1-adrenergic receptors of Kupffer cells.
Huan HB; Wen XD; Chen XJ; Wu L; Wu LL; Zhang L; Yang DP; Zhang X; Bie P; Qian C; Xia F
Brain Behav Immun; 2017 Jan; 59():118-134. PubMed ID: 27585737
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
[TBL] [Abstract][Full Text] [Related]
38. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
Saber S; Mahmoud AAA; Goda R; Helal NS; El-Ahwany E; Abdelghany RH
Toxicol Lett; 2018 Oct; 295():32-40. PubMed ID: 29859236
[TBL] [Abstract][Full Text] [Related]
39. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
40. NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.
Lu X; Ma P; Shi Y; Yao M; Hou L; Zhang P; Jiang L
Mol Cell Endocrinol; 2015 Feb; 401():1-11. PubMed ID: 25448063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
